Y.Enterocolitica (O:9) YopH

Yersinia Enterocolitica (O:9) YopH Recombinant
Shipped with Ice Packs
In Stock

Description

Molecular Function and Pathogenic Role

YopH (synonym: Yop51) disrupts host cell signaling by dephosphorylating key proteins involved in phagocytosis and immune activation . Its enzymatic activity targets:

  • Focal adhesion kinases (FAK) and paxillin, impairing actin cytoskeleton reorganization required for phagocyte engulfment .

  • CXCR2 chemokine receptors on neutrophils, reducing their migration to infection sites like Peyer’s patches (PP) .

Virulence Mechanisms in Animal Models

Studies using YopH-deficient mutants (Y. enterocolitica ΔyopH) reveal its critical role in immune evasion:

ParameterWild-Type StrainΔyopH MutantSource
Mouse survival rate45% mortality100% survival
Bacterial load in PP (3 dpi)4–5 log CFU/mg<1 log CFU/mg
Neutrophil recruitment to PPImpairedEnhanced
  • Key findings:

    • The ΔyopH mutant induces CXCL1 (neutrophil chemoattractant) and upregulates CXCR2 receptor expression on circulating neutrophils, enabling efficient PP infiltration .

    • Coinfection with ΔyopH and wild-type strains accelerates WT clearance due to neutrophil-mediated phagocytosis .

Immune Evasion Strategies

YopH synergizes with other Yops (e.g., YopE, YopT) to block phagocytosis:

  • Non-opsonic phagocytosis: YopH, YopE, and YopT inhibit Rac/Rho GTPase signaling, preventing actin polymerization .

  • Opsonized phagocytosis: YopH and YopO destabilize Fcγ receptor-mediated engulfment in macrophages .

Therapeutic and Research Applications

The ΔyopH strain is being explored as an oral vaccine carrier due to its avirulence and ability to induce protective immunity . Commercial YopH proteins are available for research:

Product CodeQuantityPriceSupplier
A4340050 µg$150.00Surmodics
A434011.0 mg$1,710.00Surmodics

Future Research Directions

  • Mechanistic studies: Elucidate YopH’s molecular targets in CXCR2 regulation and neutrophil chemotaxis .

  • Vaccine development: Optimize ΔyopH strains for mucosal immunity against Yersinia and other enteric pathogens .

Q&A

What is Y. enterocolitica YopH and what is its precise role in bacterial virulence?

YopH is a tyrosine phosphatase critical for Y. enterocolitica virulence that is secreted via the Ysc type III secretion system. This sophisticated system enables extracellular adherent bacteria to inject Yop effectors directly into the cytosol of host cells . YopH specifically disrupts host defense mechanisms by interfering with intracellular signaling pathways that regulate immune responses. Research demonstrates that YopH-deficient strains (Y. enterocolitica ΔyopH) show significant attenuation in virulence, are efficiently eliminated from Peyer's patches after oral infection, and fail to disseminate to the spleen, unlike wild-type strains that exhibit a characteristic biphasic infection pattern .

How does YopH contribute to immune evasion mechanisms during Y. enterocolitica infection?

YopH employs multiple sophisticated mechanisms to evade host immunity:

  • Prevents neutrophil recruitment to infection sites, particularly Peyer's patches

  • Modulates expression of CXCR2 (the receptor for neutrophil chemoattractant CXCL1) on blood neutrophils

  • Acts synergistically with other Yop effectors (YopE, YopT, and YopO) to increase resistance to both opsonic and non-opsonic phagocytosis by macrophages and polymorphonuclear leukocytes (PMNs)

  • Disrupts host cell signaling pathways critical for immune cell function

Experimental evidence shows that YopH-deficient strains induce significantly enhanced neutrophil recruitment to Peyer's patches compared to wild-type infections (p < 0.001), demonstrating YopH's crucial role in suppressing this critical innate immune response .

What is the comparative colonization pattern between wild-type Y. enterocolitica and YopH-deficient strains?

The colonization patterns differ significantly between wild-type and YopH-deficient strains:

ParameterY. enterocolitica Wild-TypeY. enterocolitica ΔyopHSignificance
Peyer's patches colonizationBiphasic pattern with persistent infectionRapid eliminationp < 0.001
Spleen disseminationSignificant bacterial burdenMinimal to no detectionp < 0.001
Mouse survival rateLowerHigherp < 0.001

Wild-type Y. enterocolitica demonstrates a biphasic colonization pattern in Peyer's patches, with an initial colonization followed by a second increase in bacterial load that corresponds with dissemination to the spleen . In contrast, YopH-deficient strains are rapidly cleared from Peyer's patches without establishing systemic infection, indicating YopH's critical role in pathogenesis and immune evasion .

How specifically does YopH interfere with neutrophil recruitment during Y. enterocolitica infection?

YopH's interference with neutrophil recruitment involves a sophisticated interplay between chemokine production and receptor expression:

  • While wild-type Y. enterocolitica induces higher levels of neutrophil chemoattractant CXCL1 in Peyer's patches, infection with YopH-deficient strains leads to significantly higher expression of the CXCL1 receptor (CXCR2) on blood neutrophils

  • This enhanced CXCR2 expression in YopH-deficient infection facilitates more efficient neutrophil recruitment to Peyer's patches

  • In vitro infection of blood neutrophils confirms YopH's direct involvement in modulating CXCR2 expression

  • Quantitative analysis reveals that wild-type Y. enterocolitica infection results in higher neutrophil numbers in the blood but lower infiltration into Peyer's patches compared to YopH-deficient strains

Flow cytometry analysis demonstrates significantly higher frequency and absolute numbers of CD11b+Ly6G+ neutrophils in Peyer's patches of mice infected with Y. enterocolitica ΔyopH compared to wild-type infection (p < 0.001) .

What is the functional importance of neutrophils in controlling Y. enterocolitica ΔyopH infection?

Neutrophils play a critical role in the elimination of YopH-deficient Y. enterocolitica:

  • Depletion of neutrophils during Y. enterocolitica ΔyopH infection significantly increases bacterial load in Peyer's patches, confirming neutrophils' essential role in controlling this attenuated strain

  • Histological studies show that in uninfected mice, neutrophils are predominantly located in blood vessels, while in Y. enterocolitica ΔyopH infection, they migrate extensively into the tissue

  • Neutrophil recruitment correlates directly with bacterial clearance, demonstrating their mechanistic importance in host defense against Y. enterocolitica

This evidence establishes neutrophils as key cellular mediators in the early immune response against Y. enterocolitica and identifies YopH as a critical bacterial factor that counteracts this defensive mechanism .

What is the synergistic relationship between YopH and other Yop effector proteins in phagocytosis resistance?

YopH functions cooperatively with other Yop effectors to prevent phagocytosis:

Experimental evidence shows that single-mutant bacteria lacking either YopE, YopH, YopT, or YopO are significantly more susceptible to phagocytosis than wild-type bacteria . Notably, overexpression of any single Yop effector does not confer full resistance to phagocytosis, despite affecting the cytoskeleton, demonstrating that these effectors must work synergistically for complete phagocytosis inhibition .

How do the phagocytosis resistance mechanisms differ between macrophages and polymorphonuclear leukocytes (PMNs)?

The effectiveness of Yop effectors shows cell-type specificity:

  • YopH, YopT, and YopO play significant roles in resistance to both opsonic and non-opsonic phagocytosis by both macrophages and PMNs

  • YopE's contribution varies by context - it plays a significant role in non-opsonic phagocytosis by both cell types but shows a differential effect in opsonic phagocytosis (significant in PMNs but not in J774 macrophages)

  • Opsonized YopE-deficient mutants are phagocytosed significantly more than wild-type bacteria by PMNs but not by J774 macrophages

  • These differences suggest cell-specific mechanisms and signaling pathways targeted by different Yop effectors

These findings emphasize the sophisticated nature of Y. enterocolitica's anti-phagocytic strategies and highlight the importance of studying these mechanisms in multiple cell types .

What are the optimal experimental models for studying Y. enterocolitica YopH functions?

Researchers should consider these validated experimental systems:

  • In vivo models: Oral infection of mice with wild-type or YopH-deficient Y. enterocolitica strains with analysis of bacterial colonization, immune cell recruitment, and systemic dissemination

  • Co-infection models: Equal mixture of wild-type and YopH-deficient strains (2.5 × 10^8 of each) to assess competitive dynamics and potential protective effects

  • Cell culture systems: J774 mouse macrophages and human PMNs for phagocytosis assays with appropriate opsonization (anti-Y. enterocolitica O:9 LPS rabbit serum for J774 cells)

  • In vitro neutrophil assays: Isolated blood neutrophils to study CXCR2 expression and other cellular responses

  • Neutrophil depletion studies: To establish the causal role of neutrophils in bacterial clearance

Each model offers distinct advantages for investigating different aspects of YopH biology and host-pathogen interactions .

What techniques are most effective for analyzing the impact of YopH on neutrophil function?

For comprehensive analysis of YopH effects on neutrophils, researchers should employ:

  • Flow cytometry: Quantification of CD11b+Ly6G+ neutrophils in tissues and assessment of activation markers (e.g., CD11b expression)

  • Histological and immunofluorescence analyses: Visualization of neutrophil distribution in tissues and bacterial colonies

  • Neutrophil infiltration rate calculation: Ratio of tissue neutrophils to blood neutrophils to normalize for systemic neutrophilia

  • Chemokine/receptor expression analysis: qPCR and protein-level analysis of CXCL1 and CXCR2

  • Bacterial load determination: Culture-based quantification with appropriate antibiotic selection markers (e.g., kanamycin resistance for YopH-deficient strains)

Combining these methodologies provides comprehensive insights into how YopH modulates neutrophil recruitment and function during infection .

How can YopH-deficient Y. enterocolitica strains be utilized in vaccine development?

YopH-deficient strains demonstrate several promising characteristics for vaccine applications:

  • Attenuated virulence with preserved immunogenicity: They colonize Peyer's patches transiently without causing systemic infection

  • Enhanced immune stimulation: They induce robust neutrophil recruitment to infection sites

  • Protective effects in co-infection: When co-administered with wild-type Y. enterocolitica, they promote complete elimination of the virulent strain

  • Induction of specific immunity: They can generate mucosal and systemic Yersinia-specific IgA responses

  • Self-limiting infection: They are efficiently cleared from the host without requiring IL-12, IL-18, TNF-Rp55, IFN-γ, or IL-6 dependent immune mechanisms

Experimental data shows that co-infection with Y. enterocolitica ΔyopH results in complete elimination of wild-type Y. enterocolitica, contrasting with the high bacterial load observed after infection with wild-type bacteria alone, both in Peyer's patches and feces at 3 days post-infection .

What are the key considerations for developing YopH-targeted vaccine strategies?

When developing vaccines based on YopH-deficient strains, researchers should consider:

  • Dosage optimization: Determining the minimal effective dose for colonization without adverse effects

  • Route of administration: Oral delivery to target intestinal Peyer's patches

  • Strain engineering: Potential introduction of heterologous antigens into the YopH-deficient background

  • Immune response characterization: Comprehensive analysis of both innate and adaptive immune responses

  • Duration of protection: Assessment of long-term immunity and potential need for boosting

  • Cross-protection: Evaluation of protection against different Y. enterocolitica serotypes or even related Yersinia species

These considerations are critical for translating the promising characteristics of YopH-deficient strains into effective vaccine candidates against Y. enterocolitica and potentially as vectors for delivering antigens from other pathogens .

What are the current challenges in elucidating the complete molecular mechanism of YopH activity?

Researchers face several challenges in fully characterizing YopH function:

  • Comprehensive substrate identification: Determining the complete repertoire of host proteins dephosphorylated by YopH in different cell types

  • Temporal dynamics: Understanding how YopH activity changes during different phases of infection

  • Context-dependent effects: Elucidating how YopH functions differently in various tissue environments and cell types

  • Interaction with other Yops: Mapping the complex interplay between YopH and other virulence factors

  • Species and serotype variations: Characterizing potential differences in YopH function across Y. enterocolitica serotypes, including O:9

Addressing these challenges requires integrative approaches combining molecular, cellular, and systems biology methodologies .

How does the mechanistic understanding of YopH inform broader concepts in bacterial pathogenesis?

The study of YopH provides insights into fundamental concepts in pathogenesis:

  • Sophisticated immune evasion strategies: YopH exemplifies how bacterial pathogens can precisely target critical immune pathways

  • Temporal regulation of virulence: The biphasic nature of wild-type Y. enterocolitica infection reveals how pathogens can modulate their virulence program over time

  • Cell-type specific targeting: Differential effects of YopH on various immune cells illustrates the specificity of bacterial virulence factors

  • Cooperative virulence mechanisms: The synergistic action of multiple Yop effectors demonstrates how pathogens employ coordinated attacks on host defenses

  • Balance between immunogenicity and virulence: YopH-deficient strains highlight how attenuated pathogens can retain immunogenicity while losing virulence

These concepts extend beyond Yersinia and inform our understanding of bacterial pathogenesis more broadly .

Product Science Overview

Serotype O:9

Yersinia enterocolitica is classified into various serotypes based on the structure of its lipopolysaccharides (LPS). One of the significant serotypes is O:9, which is known for its pathogenicity and ability to cause disease in humans. This serotype has been implicated in several outbreaks of yersiniosis, a disease characterized by symptoms such as diarrhea, fever, and abdominal pain.

YopH Protein

The YopH protein is a virulence factor produced by Yersinia enterocolitica. It is a tyrosine phosphatase enzyme that plays a crucial role in the bacterium’s ability to evade the host immune system. By dephosphorylating key signaling molecules in host cells, YopH disrupts normal cellular functions, thereby aiding in the bacterium’s survival and proliferation within the host.

Recombinant YopH

Recombinant YopH refers to the YopH protein that has been produced using recombinant DNA technology. This involves inserting the gene encoding YopH into a suitable expression system, such as E. coli, to produce the protein in large quantities. The recombinant YopH protein is typically tagged with a histidine (His) tag to facilitate its purification using chromatographic techniques .

Applications

Recombinant YopH has several applications in research and diagnostics:

  1. Immunological Studies: It is used to study the immune response to Yersinia infections. By binding to human antibodies of the IgG, IgM, and IgA types, recombinant YopH can help in understanding the host-pathogen interactions.
  2. Diagnostic Tests: Recombinant YopH is used in immunodot tests to differentiate between positive and negative sera panels, aiding in the diagnosis of yersiniosis.
  3. Vaccine Development: Research on recombinant YopH can contribute to the development of vaccines against Yersinia infections by identifying potential antigenic targets.
Storage and Stability

Recombinant YopH is typically supplied in a sterile filtered solution containing HEPES buffer, NaCl, and glycerol. It is recommended to store the protein at -20°C for long-term stability, although it can be kept at 4°C if used within 2-4 weeks. Multiple freeze-thaw cycles should be avoided to maintain the protein’s integrity .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.